Entering text into the input field will update the search result below

Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q1 2020 Results - Earnings Call Transcript

May 07, 2020 9:22 PM ETLisata Therapeutics, Inc. (LSTA)
SA Transcripts profile picture
SA Transcripts

Caladrius Biosciences, Inc. (CLBS) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET

Company Participants

John Menditto - VP, IR & Corporate Communications

David Mazzo - President, CEO & Director

Joseph Talamo - CFO & SVP

Douglas Losordo - EVP, Global Head, R&D & Chief Medical Officer

Conference Call Participants

Emanuela Branchetti - H.C. Wainwright & Co.

Peter Enderlin - MAZ Capital Advisors


Hello, and welcome to the Caladrius Biosciences First Quarter 2020 Financial Results and Business Update Conference Call. [Operator Instructions]. As a reminder, this call is being recorded today, Thursday, May 7, 2020.

I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Caladrius. Please go ahead, sir.

John Menditto

Good afternoon, and thank you all for participating in today's call. Joining me today from our management team are Dr. David Mazzo, President and Chief Executive Officer; Dr. Douglas Losordo, Chief Medical Officer; and Joseph Talamo, Chief Financial Officer. Earlier today, we issued a press release announcing our 2020 first quarter financial results. If you have not received this news release or if you would like to be added to the company's e-mail distribution list, please e-mail me at jaymenditto@caladrius.com.

Before we begin, I will remind you that comments made by management during this conference call will contain forward-looking statements that involve risks and uncertainties regarding the operations and future results of Caladrius. I encourage you to review the company's filings with the Securities and Exchange Commission, including, without limitation, its Forms 10-K, 10-Q and 8-K, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Furthermore, the content of this conference call contains time-sensitive information that is accurate only as of the date of this

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.